Abstract
In this article I present the partial results of an ongoing ethnographic research addresses to buprenorfine medicaments (Subutex, Suboxone etc.), buprenorfine market and substitution treatment as such. I do outline the power networks of some major players in the substitution market - drug users, institutions, buprenorphine itself and other actors.
I try to capture multiplicity of the issue by the specific example of so-called "Subutex crisis"